Optimal recall periods for patient-reported outcomes: challenges and potential solutions

Donald E. Stull(United BioSource Corporation (United Kingdom)), Olivier Chassany(Inserm), Bhash Parasuraman(AstraZeneca (United States)), Nancy Kline Leidy(Health Outcomes Solutions (United States))
Current Medical Research and Opinion
February 27, 2009
10.1185/03007990902774765
Cited by 404

Related Papers

Development and first validation of the COPD Assessment Test
|European Respiratory Journal|2009|3.2k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 2—Assessing Respondent Understanding
|Value in Health|2011|1.1k
Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO Instrument
|Value in Health|2011|1.1k
Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues
|Value in Health|2004|695
Recommendations on health-related quality of life research to support labeling and promotional claims in the United States
|Quality of Life Research|2000|575